$2.12
0.95% yesterday
Nasdaq, Nov 15, 10:11 pm CET
ISIN
US29664W1053
Symbol
ESPR
Sector
Industry

Esperion Therapeutics, Inc. Stock News

Positive
Seeking Alpha
3 days ago
I maintain my buy rating on Esperion Therapeutics due to its strong Q3 2024 financial performance, showcasing consistent revenue growth and market adoption. The Company's aggressive commercialization efforts, including market coverage expansion and sales force growth, have significantly boosted retail prescriptions and broadened future revenue streams. International expansion through partnershi...
Neutral
GlobeNewsWire
7 days ago
ANN ARBOR, Mich., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 7, 2024, the Company granted four new employees 12,900 restricted stock units (RSUs) under Esperion's 2017 Inducement Equity Incentive Plan.
Neutral
Seeking Alpha
8 days ago
Esperion Therapeutics, Inc. (ESPR) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
9 days ago
– Total Revenue Increased 52% Year-over-Year to $51.6 Million with  U.S. Net Product Revenue of $31.1 Million, Representing 53% Growth –
Neutral
GlobeNewsWire
12 days ago
ANN ARBOR, Mich., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 11:30 a.m. ET.
Neutral
GlobeNewsWire
23 days ago
ANN ARBOR, Mich., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report third quarter 2024 financial results before the market opens on Thursday, November 7, 2024.
Neutral
GlobeNewsWire
about 2 months ago
ANN ARBOR, Mich., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on September 23, 2024, the Company granted one new employee 3,500 restricted stock units (RSUs) under Esperion's 2017 Inducement Equity Incentive Plan.
Neutral
GlobeNewsWire
2 months ago
– New Additions to Medicare Formularies at Optum/United AARP and CVS/SilverScript Coupled with Humana Provides Access to More Than 65% of Medicare Insured Lives and More Than 92% of Commercially Insured Lives –

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today